Martingale Asset Management’s Lifecore Biomedical LFCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-24,430
| Closed | -$158K | – | 865 |
|
|
2022
Q4 | $158K | Hold |
24,430
| – | – | ﹤0.01% | 804 |
|
|
2022
Q3 | $218K | Hold |
24,430
| – | – | ﹤0.01% | 767 |
|
|
2022
Q2 | $244K | Buy |
24,430
+1,815
| +8% | +$18.1K | ﹤0.01% | 773 |
|
|
2022
Q1 | $262K | Buy |
22,615
+101
| +0.4% | +$1.17K | ﹤0.01% | 749 |
|
|
2021
Q4 | $250K | Buy |
22,514
+100
| +0.4% | +$1.11K | ﹤0.01% | 766 |
|
|
2021
Q3 | $207K | Buy |
+22,414
| New | +$207K | ﹤0.01% | 816 |
|
|
2020
Q4 | – | Sell |
-72,314
| Closed | -$704K | – | 980 |
|
|
2020
Q3 | $704K | Sell |
72,314
-89,900
| -55% | -$875K | 0.01% | 725 |
|
|
2020
Q2 | $1.29M | Hold |
162,214
| – | – | 0.02% | 672 |
|
|
2020
Q1 | $1.41M | Hold |
162,214
| – | – | 0.02% | 580 |
|
|
2019
Q4 | $1.84M | Sell |
162,214
-1,200
| -0.7% | -$13.6K | 0.02% | 614 |
|
|
2019
Q3 | $1.78M | Buy |
163,414
+19,701
| +14% | +$214K | 0.02% | 613 |
|
|
2019
Q2 | $1.35M | Sell |
143,713
-19,000
| -12% | -$178K | 0.01% | 701 |
|
|
2019
Q1 | $2M | Buy |
162,713
+45,287
| +39% | +$556K | 0.02% | 600 |
|
|
2018
Q4 | $1.39M | Buy |
117,426
+17,500
| +18% | +$207K | 0.02% | 629 |
|
|
2018
Q3 | $1.44M | Buy |
99,926
+50,203
| +101% | +$723K | 0.02% | 637 |
|
|
2018
Q2 | $741K | Buy |
49,723
+22,805
| +85% | +$340K | 0.01% | 795 |
|
|
2018
Q1 | $352K | Hold |
26,918
| – | – | ﹤0.01% | 863 |
|
|
2017
Q4 | $340K | Sell |
26,918
-1,000
| -4% | -$12.6K | ﹤0.01% | 875 |
|
|
2017
Q3 | $362K | Sell |
27,918
-1,200
| -4% | -$15.6K | ﹤0.01% | 884 |
|
|
2017
Q2 | $433K | Buy |
+29,118
| New | +$433K | 0.01% | 843 |
|